Immix Biopharma (IMMX) Total Current Liabilities (2020 - 2026)
Quarterly results put Total Current Liabilities at $10.5 million for Q1 2026, up 13.24% from a year ago — trailing twelve months through Mar 2026 was $10.5 million (up 13.24% YoY), and the annual figure for FY2025 was $10.1 million, up 16.39%.
Immix Biopharma has reported Total Current Liabilities over the past 7 years, most recently at $10.5 million for Q1 2026.
- Total Current Liabilities reached $10.5 million in Q1 2026 per IMMX's latest filing, up from $10.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $10.9 million in Q3 2025 and bottomed at $365086.0 in Q1 2022.
- Median Total Current Liabilities over the past 5 years was $3.9 million (2024), compared with a mean of $5.3 million.
- The largest annual shift saw Total Current Liabilities surged 530.22% in 2022 before it rose 13.24% in 2026.
- Over 5 years, Total Current Liabilities stood at $1.3 million in 2022, then soared by 192.3% to $3.7 million in 2023, then soared by 133.41% to $8.7 million in 2024, then increased by 16.39% to $10.1 million in 2025, then rose by 4.24% to $10.5 million in 2026.
- Business Quant data shows Total Current Liabilities for IMMX at $10.5 million in Q1 2026, $10.1 million in Q4 2025, and $10.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 5.11 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.54 Mn |
| Dec 31, 2025 | 10.11 Mn |
| Sep 30, 2025 | 10.85 Mn |
| Jun 30, 2025 | 10.01 Mn |
| Mar 31, 2025 | 9.31 Mn |
| Dec 31, 2024 | 8.69 Mn |
| Sep 30, 2024 | 6.56 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | 5.66 Mn |
| Dec 31, 2023 | 3.72 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 2.40 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 646,457.00 |
| Jun 30, 2022 | 977,209.00 |
| Mar 31, 2022 | 365,086.00 |
| Dec 31, 2021 | 202,039.00 |
| Dec 31, 2020 | 5.27 Mn |